• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞是一把双刃剑:肿瘤相关巨噬细胞与癌症干细胞之间的分子串扰。

Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells.

机构信息

Key Laboratory of Cell Homeostasis and Cancer Research of Guangdong Higher Education Institutes and Affiliated Cancer Hospital & Institute, Guangzhou Medical University, Guangzhou 910095, China.

Department of Surgery, Nanjing Lishui People's Hospital, Nanjing 211200, China.

出版信息

Biomolecules. 2022 Jun 19;12(6):850. doi: 10.3390/biom12060850.

DOI:10.3390/biom12060850
PMID:35740975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9221070/
Abstract

Cancer stem cells (CSCs) are a subset of highly tumorigenic cells in tumors. They have enhanced self-renewal properties, are usually chemo-radioresistant, and can promote tumor recurrence and metastasis. They can recruit macrophages into the tumor microenvironment and differentiate them into tumor-associated macrophages (TAMs). TAMs maintain CSC stemness and construct niches that are favorable for CSC survival. However, how CSCs and TAMs interact is not completely understood. An understanding on these mechanisms can provide additional targeting strategies for eliminating CSCs. In this review, we comprehensively summarize the reported mechanisms of crosstalk between CSCs and TAMs and update the related signaling pathways involved in tumor progression. In addition, we discuss potential therapies targeting CSC-TAM interaction, including targeting macrophage recruitment and polarization by CSCs and inhibiting the TAM-induced promotion of CSC stemness. This review also provides the perspective on the major challenge for developing potential therapeutic strategies to overcome CSC-TAM crosstalk.

摘要

癌症干细胞(CSCs)是肿瘤中具有高致瘤性的细胞亚群。它们具有增强的自我更新特性,通常对化疗和放疗具有抗性,并能促进肿瘤复发和转移。它们可以招募巨噬细胞进入肿瘤微环境,并将其分化为肿瘤相关巨噬细胞(TAMs)。TAMs 维持 CSC 的干性并构建有利于 CSC 存活的龛位。然而,CSCs 和 TAMs 之间的相互作用机制尚不完全清楚。了解这些机制可以为消除 CSCs 提供额外的靶向策略。在这篇综述中,我们全面总结了 CSCs 和 TAMs 之间相互作用的报道机制,并更新了涉及肿瘤进展的相关信号通路。此外,我们还讨论了针对 CSC-TAM 相互作用的潜在治疗策略,包括靶向 CSC 募集和极化巨噬细胞以及抑制 TAM 诱导的 CSC 干性促进。本文还就开发潜在治疗策略以克服 CSC-TAM 相互作用所面临的主要挑战提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1a1/9221070/4454ea2834c9/biomolecules-12-00850-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1a1/9221070/5696277509d8/biomolecules-12-00850-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1a1/9221070/4454ea2834c9/biomolecules-12-00850-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1a1/9221070/5696277509d8/biomolecules-12-00850-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1a1/9221070/4454ea2834c9/biomolecules-12-00850-g002.jpg

相似文献

1
Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells.巨噬细胞是一把双刃剑:肿瘤相关巨噬细胞与癌症干细胞之间的分子串扰。
Biomolecules. 2022 Jun 19;12(6):850. doi: 10.3390/biom12060850.
2
Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies.癌症干细胞与巨噬细胞:对肿瘤生物学及治疗策略的影响
Mediators Inflamm. 2016;2016:9012369. doi: 10.1155/2016/9012369. Epub 2016 Feb 14.
3
Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.肿瘤细胞 CD44 介导巨噬细胞/单核细胞对头颈部癌症干细胞的调控作用。
Cancer Res. 2020 Oct 1;80(19):4185-4198. doi: 10.1158/0008-5472.CAN-20-1079. Epub 2020 Aug 14.
4
Macrophages and cancer stem cells: a malevolent alliance.巨噬细胞和癌症干细胞:一个邪恶的联盟。
Mol Med. 2021 Sep 28;27(1):121. doi: 10.1186/s10020-021-00383-3.
5
Chemotherapy Enriches for Proinflammatory Macrophage Phenotypes that Support Cancer Stem-Like Cells and Disease Progression in Ovarian Cancer.化疗会富集促炎型巨噬细胞表型,从而支持卵巢癌细胞中的癌症干细胞样细胞和疾病进展。
Cancer Res Commun. 2024 Oct 1;4(10):2638-2652. doi: 10.1158/2767-9764.CRC-24-0311.
6
Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.肿瘤相关巨噬细胞通过转化生长因子-β1 诱导的上皮-间充质转化促进肝癌中的癌症干细胞样特性。
Cancer Lett. 2014 Oct 1;352(2):160-8. doi: 10.1016/j.canlet.2014.05.008. Epub 2014 Jun 2.
7
Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.大黄素通过抑制巨噬细胞诱导的乳腺癌细胞上皮-间充质转化和癌症干细胞形成来减少乳腺癌肺转移。
Theranostics. 2020 Jul 9;10(18):8365-8381. doi: 10.7150/thno.45395. eCollection 2020.
8
Induction of protumoral CD11c(high) macrophages by glioma cancer stem cells through GM-CSF.胶质瘤癌干细胞通过粒细胞-巨噬细胞集落刺激因子诱导促肿瘤性CD11c(高表达)巨噬细胞生成。
Genes Cells. 2016 Mar;21(3):241-51. doi: 10.1111/gtc.12333. Epub 2016 Jan 25.
9
IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer.M2 巨噬细胞来源的 IL-10 通过 JAK1/STAT1/NF-κB/Notch1 通路促进非小细胞肺癌中的癌症干性。
Int J Cancer. 2019 Aug 15;145(4):1099-1110. doi: 10.1002/ijc.32151. Epub 2019 Feb 7.
10
Stem cell programs in cancer initiation, progression, and therapy resistance.肿瘤起始、进展和治疗抵抗中的干细胞程序。
Theranostics. 2020 Jul 9;10(19):8721-8743. doi: 10.7150/thno.41648. eCollection 2020.

引用本文的文献

1
SERPINA1 is a new frontier in cancer immunotherapy and drug targeting by pan-cancer analysis.通过泛癌分析,丝氨酸蛋白酶抑制剂A1(SERPINA1)是癌症免疫治疗和药物靶向的一个新领域。
Discov Oncol. 2025 Jun 8;16(1):1030. doi: 10.1007/s12672-025-02832-5.
2
Emerging therapeutics targeting tumor-associated macrophages for the treatment of solid organ cancers.靶向肿瘤相关巨噬细胞治疗实体器官癌症的新兴疗法。
Expert Opin Emerg Drugs. 2025 Jun;30(2):109-147. doi: 10.1080/14728214.2025.2504376. Epub 2025 May 25.
3
The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials.

本文引用的文献

1
Tazemetostat: EZH2 Inhibitor.他泽司他:EZH2抑制剂。
J Adv Pract Oncol. 2022 Mar;13(2):158-163. doi: 10.6004/jadpro.2022.13.2.7. Epub 2022 Mar 25.
2
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression.CECR2 通过促进 NF-κB 信号通路和巨噬细胞介导的免疫抑制作用促进乳腺癌转移。
Sci Transl Med. 2022 Feb 2;14(630):eabf5473. doi: 10.1126/scitranslmed.abf5473.
3
Sox9/CXCL5 axis facilitates tumour cell growth and invasion in hepatocellular carcinoma.Sox9/CXCL5 轴促进肝癌细胞生长和侵袭。
巨噬细胞极化在卵巢癌中的作用:从分子机制到治疗潜力
Front Immunol. 2025 Apr 22;16:1543096. doi: 10.3389/fimmu.2025.1543096. eCollection 2025.
4
A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities.卵巢癌干细胞综述:与高复发率的关联、潜在机制及治疗机遇
Mol Cancer. 2025 May 7;24(1):135. doi: 10.1186/s12943-025-02345-3.
5
Breaking Immunosuppression to Enhance Cancer Stem Cell-Targeted Immunotherapy.打破免疫抑制以增强针对癌症干细胞的免疫疗法。
Int J Biol Sci. 2025 Feb 10;21(4):1819-1836. doi: 10.7150/ijbs.101025. eCollection 2025.
6
Role of the AKT signaling pathway in regulating tumor-associated macrophage polarization and in the tumor microenvironment: A review.AKT信号通路在调节肿瘤相关巨噬细胞极化及肿瘤微环境中的作用:综述
Medicine (Baltimore). 2025 Jan 31;104(5):e41379. doi: 10.1097/MD.0000000000041379.
7
The two-sided battlefield of tumour-associated macrophages in glioblastoma: unravelling their therapeutic potential.胶质母细胞瘤中肿瘤相关巨噬细胞的双面战场:揭示其治疗潜力
Discov Oncol. 2024 Oct 25;15(1):590. doi: 10.1007/s12672-024-01464-5.
8
Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies.揭示黑色素瘤中癌症干细胞与肿瘤微环境之间的动态相互作用:对新型治疗策略的启示
Cancers (Basel). 2024 Aug 16;16(16):2861. doi: 10.3390/cancers16162861.
9
Unveiling the anticancer effect of traditional Chinese herbal medicine.揭示传统中草药的抗癌作用。
World J Gastroenterol. 2024 Aug 14;30(30):3625-3627. doi: 10.3748/wjg.v30.i30.3625.
10
Immunotherapeutic Strategies Targeting Breast Cancer Stem Cells.免疫治疗策略靶向乳腺癌干细胞。
Curr Oncol. 2024 May 29;31(6):3040-3063. doi: 10.3390/curroncol31060232.
FEBS J. 2022 Jun;289(12):3535-3549. doi: 10.1111/febs.16357. Epub 2022 Jan 25.
4
Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress.靶向促氧化剂 MnSOD 抑制致癌应激下三阴性乳腺癌(TNBC)的进展和 M2 巨噬细胞功能。
Cell Death Dis. 2022 Jan 11;13(1):49. doi: 10.1038/s41419-021-04486-x.
5
M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop.M1 样肿瘤相关巨噬细胞通过 IL6/Stat3/THBS1 反馈环级联口腔鳞状细胞癌的间充质/干细胞样表型。
J Exp Clin Cancer Res. 2022 Jan 6;41(1):10. doi: 10.1186/s13046-021-02222-z.
6
HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.HLF 通过激活肿瘤细胞-巨噬细胞串扰调节三阴性乳腺癌的铁死亡、发展和化疗耐药性。
J Hematol Oncol. 2022 Jan 6;15(1):2. doi: 10.1186/s13045-021-01223-x.
7
Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges.E3 泛素连接酶在癌症免疫中的潜力:机遇与挑战。
Cells. 2021 Nov 25;10(12):3309. doi: 10.3390/cells10123309.
8
Identification of prognostic and therapeutic value of CC chemokines in Urothelial bladder cancer: evidence from comprehensive bioinformatic analysis.综合生物信息学分析鉴定 CC 趋化因子在尿路上皮膀胱癌中的预后和治疗价值。
BMC Urol. 2021 Dec 10;21(1):173. doi: 10.1186/s12894-021-00938-w.
9
M2 macrophage microvesicle-inspired nanovehicles improve accessibility to cancer cells and cancer stem cells in tumors.M2 巨噬细胞微泡启发的纳米载体提高了肿瘤中癌细胞和肿瘤干细胞的可及性。
J Nanobiotechnology. 2021 Nov 27;19(1):397. doi: 10.1186/s12951-021-01143-5.
10
Clinical relevance of stem cell surface markers CD133, CD24, and CD44 in colorectal cancer.干细胞表面标志物CD133、CD24和CD44在结直肠癌中的临床相关性
Am J Cancer Res. 2021 Oct 15;11(10):5141-5154. eCollection 2021.